Full Job Description
Azurity Pharmaceuticals is seeking a Director, Medical Lead to provide strategic medical leadership across the Oncology Franchise (ONCO). This role serves as the senior medical strategist responsible for ensuring scientific rigor, consistency, and alignment of medical strategy across brands and indications within the portfolio.
Reporting to the VP Medical Strategy Executive, the Medical Lead will ensure high-quality medical strategy development, evidence planning, and cross-functional execution in support of global markets.
Key Responsibilities
Portfolio Medical Strategy Leadership
• Lead and integrate medical strategy across Oncology Franchise (ONCO), ensuring alignment with enterprise medical objectives.
• Translate scientific data, unmet need, and external insights into clear, differentiated medical strategies at the portfolio and brand level.
• Ensure consistency of medical positioning, evidence priorities, and scientific narratives across indications and regions.
Leadership of Medical Directors
• Provide direct leadership, mentorship, and oversight to Medical Manager supporting the portfolio.
• Establish standards, frameworks, and expectations for medical strategic planning, execution, and measurement.
• Foster strong strategic capability and scientific leadership across the Medical Strategy team.
Integrated Brand & Lifecycle Planning
• Partner closely with Commercial Brand Teams to align medical strategy with brand strategy, launch readiness, and lifecycle planning-while maintaining appropriate medical independence.
• Collaborate with Franchise Portfolio Management Team to inform indication sequencing, portfolio prioritization, and long-range lifecycle strategy.
• Oversee medical contributions to integrated brand plans, including pre-launch, launch, and post-launch phases.
Evidence Generation & Scientific Insight
• Guide development of evidence generation strategies, including investigator-initiated studies (IIS), real-world evidence (RWE), and post-marketing research.
• Ensure medical strategies are informed by clinical data, real-world insights, guidelines, and evolving standards of care.
• Leverage insights from MSLs, KOLs, advisory boards, and congresses to continuously refine strategy.
Cross-Functional & Executive Collaboration
• Serve as a senior medical strategy partner to Medical Affairs, Clinical Development, Regulatory, Market Access, Safety, and Global Medical Operations.
• Provide medical strategic input into value, access, and reimbursement discussions relevant to the portfolio.
• Support business development and due diligence activities through medical assessment of potential assets.
Governance & Scientific Integrity
• Ensure all medical strategies and activities adhere to global medical governance standards, regulatory requirements, and ethical principles.
• Partner with Legal and Compliance to maintain appropriate separation between medical and commercial activities.
• Advanced degree required: MD, PharmD, PhD, or equivalent medical/scientific degree.
Experience
• 10+ years of experience in Medical Affairs, Clinical Development, or medical strategy roles within pharmaceutical or biotech organizations.
• Demonstrated leadership of Medical Directors or senior medical strategists.
• Experience supporting therapeutic areas within oncology.
• Proven success partnering with Commercial and Portfolio Management teams in a matrixed environment.
• Experience supporting global portfolios and multiple product lifecycles.
Skills & Competencies
• Strong portfolio-level strategic thinking and scientific judgment.
• Proven people leader with experience developing senior medical talent.
• Excellent executive communication and stakeholder-management skills.
• Deep understanding of drug development, evidence generation, and medical governance.
• High ethical standards and strong patient-centric orientation.
Preferred Qualifications
• Experience in specialty pharma or complex therapeutic portfolios.
• Experience working across US and international markets.
• Prior involvement in multiple launches and lifecycle expansions.
• Experience supporting franchise- or portfolio-based operating models.
Travel
• Willingness to travel domestically and internationally up to 25-35%
#LI-Onsite
#LI-Full-time
